IL-21 promotes the development of a CD73-positive Vγ9Vδ2 T cell regulatory population-Reference-Cited by-同舟云学术

IL-21 promotes the development of a CD73-positive Vγ9Vδ2 T cell regulatory population

Published:2017-10-04 Issue:1 Volume:7 Page:e1379642
ISSN:2162-402X
Container-title:OncoImmunology
language:en
Short-container-title:OncoImmunology

Author:

Barjon Clément¹,Michaud Henri-Alexandre¹,Fages Angeline¹,Dejou Cécile²,Zampieri Alexandre¹,They Laetitia¹,Gennetier Aurélie¹,Sanchez Françoise¹,Gros Laurent¹,Eliaou Jean-François¹²³,Bonnefoy Nathalie¹,Lafont Virginie¹³

Affiliation:

1. Institut de Recherche en Cancérologie de Montpellier (IRCM); INSERM, U1194; Université Montpellier; Institut Régional du Cancer de Montpellier (ICM), Montpellier, France

2. OREGA Biotech, Ecully, France

3. Département d'Immunologie, Centre Hospitalier Universitaire de Montpellier et Faculté de Médecine, Université de Montpellier, Hôpital Saint-Eloi, Montpellier cedex 5, France

Publisher

Informa UK Limited

Subject

Oncology,Immunology,Immunology and Allergy

Link

https://www.tandfonline.com/doi/pdf/10.1080/2162402X.2017.1379642

Reference42 articles.

1. IL-17-producing γδ T cells

2. γδ T cell effector functions: a blend of innate programming and acquired plasticity

3. γδ Cells: A Right Time and a Right Place for a Conserved Third Way of Protection

4. Identification of (E)-4-hydroxy-3-methyl-but-2-enyl pyrophosphate as a major activator for human γδ T cells inEscherichia coli

5. Cutting Edge: Human γδ T Cells Are Activated by Intermediates of the 2-C-methyl-d-erythritol 4-phosphate Pathway of Isoprenoid Biosynthesis

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Human gamma-delta (γδ) T cell therapy for glioblastoma: A novel alternative to overcome challenges of adoptive immune cell therapy;Cancer Letters;2023-09

2. Vγ9Vδ2 T-cell immunotherapy in blood cancers: ready for prime time?;Frontiers in Immunology;2023-04-18

3. Gamma delta T-cell-based immune checkpoint therapy: attractive candidate for antitumor treatment;Molecular Cancer;2023-02-15

4. Baseline Cytokine Profile Identifies a Favorable Outcome in a Subgroup of Colorectal Cancer Patients Treated with Regorafenib;Vaccines;2023-02-02

5. Identification of the immunosuppressive effect of γδ T cells correlated to bone morphogenetic protein 2 in acute myeloid leukemia;Frontiers in Immunology;2022-10-17